MedTrace Logo

Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline

NCT06893835 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2025-03-25

No results posted yet for this study

Summary

Objective from this study to compare the clinical outcomes and safety between colistin and tigecycline for multi-drug resistant gram negative bacteria.

Conditions

  • Infection in ICU

Interventions

DRUG

Colistimethate Sodium

compare the clinical outcomes and safety between colistin and tigecycline for multi-drug-resistant gram-negative bacteria.

DRUG

Tigecycline

compare the clinical outcomes and safety between colistin and tigecycline for multi-drug-resistant gram-negative bacteria.

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Shimaa N Abd elfatah, PhD · Beni-Suef University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2025-05-30
Completion
2025-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06893835 on ClinicalTrials.gov